Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for UNH and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for UNH and 80,000+ other tickers.
See exactly how UNH's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for UNH and 80,000+ other tickers.
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for…
FAST, GD, UNH, TXRH and DGX are five stocks that combine long records of uninterrupted payouts with stable earnings and solid cash flow.
The leading health insurer recently posted strong quarterly results that could drive the stock higher.
Does UnitedHealth Group (UNH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Broderick Brian C cut its position in UnitedHealth Group Incorporated (NYSE: UNH) by 55.4% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,286 shares of the healthcare conglomerate's stock after selling 6,558 shares during the quarter. Broderick Brian C's holdings in
Dimensional Fund Advisors LP lessened its holdings in UnitedHealth Group Incorporated (NYSE: UNH) by 5.1% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,000,063 shares of the healthcare conglomerate's stock after selling 266,112 shares during the period. Dimensional Fund Advisors LP